The distribution pattern of intravenous [14C] artesunate in rat tissues by quantitative whole-body autoradiography and tissue dissection techniques

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 876-884

  Li, Qigui ^a   Xie, Lisa ^a   Zhang, Jing ^a   Weina, Peter J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

14C Artesunate; Dihydroartemisinin; LSC; Pharmacokinetics; QWBA; Rats; Tissue distribution

Indexed keywords

ARTESUNATE; CARBON 14; DIHYDROARTEMISININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DISSECTION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; ENTEROHEPATIC CIRCULATION; INTERMETHOD COMPARISON; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AREA UNDER CURVE; ARTEMISININS; AUTORADIOGRAPHY; CALIBRATION; CARBON RADIOISOTOPES; DATA COLLECTION; DISSECTION; INJECTIONS, INTRAVENOUS; MALE; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; SCINTILLATION COUNTING; THERAPEUTIC EQUIVALENCY; TISSUE DISTRIBUTION;

EID: 53049104817     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.07.015     Document Type: Article

References (34)

1. Ullberg S. Acta Radiol. Suppl. 118 (1954) 1-110
2. Motoji N., Hayama E., and Shigematsu A. Eur. J. Drug Metab. Pharmacokinet. 20 (1995) 89-105
3. van Beijsterveldt L., Geerts R., Verhaeghe T., Willems B., Bode W., Lavrijsen K., and Meuldermans W. Arzneim-Forsch/Drug Res. 54 (2004) 85-94
4. Inazawa K., Koike M., and Yamaguchi T. Exp. Mol. Pathol. 76 (2004) 153-165
5. Jacob S., and Ahmed A.E. Pharmcol. Res. 48 (2003) 479-488
6. Kai K., Satoh H., Kajimura T., Kato M., Uchida K., Yamaguchi R., Tateyama S., and Furuhama K. Toxicol. Pathol. 32 (2004) 701-709
7. Solon E.G., and Lee F. J. Pharmcol. Toxicol. Methods 46 (2002) 83-91
8. Busch U., Heinzel G., and Nehmiz G. Regul. Toxicol. Pharmacol. 31 (2000) S45-S50
9. d'Argy R., and Sundwallx A. Regul. Toxicol. Pharmacol. 31 (2000) S57-S62
10. Steinke W., Archimbaut Y., Becka M., Binder R., Busch U., Dupont P., and Maas J. Regul. Toxicol. Pharmacol. 31 (2000) S33-S43
11. Li Q., Xie L.H., Haeberle A., Zhang J., and Weina J.P.J. Am. J. Trop. Med. Hyg. 75 (2006) 817-826
12. Potchoiba M.J., West M., and Nocerini M.R. Drug Metab. Dispos. 26 (1998) 272-277
13. Schweitzer A., Fahr A., and Niederberger W. Int. J. Rad. Appl. Instrum. [A] 38 (1987) 329-333
14. Solon E.G., and Kraus L. J. Pharmacol. Toxicol. Methods 46 (2001) 73-81
15. Li Q., Xie L.H., Si Y.Z., Wong E., Upadhyay R., Yanez D., and Weina P.J. Int. J. Toxicol. 24 (2005) 241-250
16. Schmitt W. Toxicol. In Vitro. 22 (2008) 457-467
17. Rodgers T., and Rowland M. J. Pharm. Sci. 95 (2006) 1238-1257
18. FDA Guidance for Industry, 2001, http://www.fda.gov/cder/guidance/3616fnl.htm.
19. FDA Guidance for Industry, 2003, http://www.fda.gov/CDER/guidance/5356fnl.pdf.
20. Cao X.T., Bethell D.B., Pham T.P., Ta T.T., Tran T.N., Nguyen T.T., Pham T.T., Nguyen T.T., and Day N.P. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 335-342
21. Itoda I., Yasunami T., Kikuchi K., Yamaura H., Totsuka K., Yoshinaga K., Teramura M., Mizoguchi H., Hatabu T., and Kano S. Kansenshogaku. Zasshi. 76 (2002) 600-603
22. Ribeiro I.R., and Olliaro P. Med. Trop. (Mars). 58 (1998) 50-53
23. Same-Ekobo A., Lohoue J., Essono E., and Ravinet L. Med. Trop. (Mars). 59 (1999) 43-45
24. Yoshizawa S., Hike K., Kimura K., Matsumoto T., Furuya N., Tateda K., Kano S., and Yamaguchi K. Kansenshogaku. Zasshi. 76 (2002) 888-892
25. Xie L.H., Johnson T.O., Weina P.J., Si Y.Z., Haeberte A.S., Upadhyay R., Wong E., and Li Q.G. Int. J. Toxicol. 24 (2005) 251-264
26. Lindholm A., Henricsson S., and Dahlqvist R. Br. J. Clin. Pharmacol. 29 (1990) 541-548
27. Matsuzawa Y., and Nakase T. J. Pharmacobio-dyn. 7 (1984) 776-783
28. Westerling D., Frigren L., and Hoglund P. Ther. Drug Monit. 15 (1993) 364-374
29. Suttle A.B., and Brouwer K.L. Drug Metab. Dispos. 22 (1994) 224-232
30. Brewster D., Humphrey M.J., and McLeavy M.A. Xenobiotica 11 (1981) 189-196
31. Ogiso T., Kitagawa T., Iwaki M., and Tanino T. Biol. Pharm. Bull. 20 (1997) 405-410
32. Scharl A., Beckmann M.W., Artwohl J.E., Kullander S., and Holt J.A. Int. J. Radiat. Oncol. Biol. Phys. 21 (1991) 1235-1240
33. Visser T.J., Rutgers M., de Herder W.W., Rooda S.J., and Hazenberg M.P. Acta Med. Austriaca 15 (1988) 37-39
34. Rodgers T., and Rowland M. J. Pharm. Sci. 95 (2006) 1238-1257 (erratum in: J. Pharm. Sci. 96 (2007) 3153-3154).